Author:
Beane Olivia S.,Darling Louise E. O.,Fonseca Vera C.,Darling Eric M.
Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Science Foundation
Wellesley College
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology
Reference55 articles.
1. Wisnivesky, J. P., Smith, C. B., Packer, S., et al. (2011). Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study. BMJ, 343, d4013.
2. Berry, D. A., Cronin, K. A., Plevritis, S. K., et al. (2005). Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine, 353, 1784–1792.
3. Saltz, L. B., & Kemeny, N. E. (1996). Adjuvant chemotherapy of colorectal cancer. The Oncologist, 1, 22–29.
4. Gerber, D. E. (2008). Targeted therapies: a new generation of cancer treatments. American Family Physician, 77, 311–319.
5. Deep, G., & Agarwal, R. (2008). New combination therapies with cell-cycle agents. Current Opinion in Investigational Drugs, 9, 591–604.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献